Improving global healthcare access thanks to a continuous and sustainable mRNA manufacturing solution.
Dillico was cofounded by senior industry experts for the purpose of developing and marketing a unique integrated and digitalized all-scale-range mRNA drug product manufacturing solution.
With its continuous and automated mRNA-LNP manufacturing system, Dillico is revolutionizing the landscape of the biopharma industry.
Our proprietary flow technology and unique production process allow for the production of mRNA vaccines and therapies at any scale, from discovery to commercial manufacturing, using the same piece of equipment. This continuous all-scale solution significantly reduces the time and effort that goes into development, as well as offering unmatched flexibility in terms of production capacity.
TEAM
Christophe Bonneville
CEO & co-founder
Christophe Bonneville leads the company’s global strategy with a vision that champions the adoption of Pharma 4.0 solutions on the global pharma market. Previously, he was co-founder and CEO of Resolution Spectra, which was acquired by Merck Millipore in 2020 for its bioprocess monitoring solution. He has also held Business Unit Manager and Program Manager roles at various companies in the space industry. He holds a PhD in Physics, specifically in the field of Instrumental Optics, and is a graduate of Ecole Centrale de Marseille in France.
Flora Binder
Chief Development Officer & co-founder
Flora leads the process development of Dillico’s technology to provide robust, fully digitized and optimized manufacturing solutions. Previously, she has been working at Moderna and Biogen in Manufacturing Science, she was responsible for process technology transfer and validation activities. She received her Masters Degree in Biotechnology from Grenoble Alpes University.
Emmanuel Gaud
Chief Operating officer & co-founder
Emmanuel Gaud acts as a Chief Operating Officer. After completion of AgroParis Tech School, Emmanuel has been working with passion in the Life Science Industries. For 23 years, he has built process system design addressing the food, cosmetics, pharmaceutical and biotech market. Emmanuel is now putting his strength working with Dillico to bring to life the manufacturing solution.
Daniel Marquez Martin
Process Scientist
Jean de Seze
Development Scientist
Lucas Audoui
Senior Process Equipment Engineer
Brice Pawelec
Process Engineer
Strategic Board
Flora Binder
Co-founder & Observer
Christophe Bonneville
Co-founding CEO & Chairperson
Marie Chambobut
Board Member
Eva Clerc
Board Member
Emmanuel Gaud
Co-founder & Observer
Maximilien Glenat
Board Member
Guillaume Leroy
Board Member
NEWS
Dillico to take advantage of Rhône-Alpes and Grenoble’s strong academic and high-technology industrial roots
Dillico is located in Grenoble, in the French Alps. It is not only a beautiful region, but also a place with a strong local environment to support future growth. GRENOBLE Highest density [...]
Welcome!
We are pleased to welcome you to our new website. Until now, Dillico has remained very discreet, focusing on exchanges with the main players in the mRNA field - we are now [...]
PARTNERS
They trust us
